HOME >> BIOLOGY >> NEWS
Statins, other cholesterol depletors, may disrupt hypertension development: UCSD study

San Diego (April 3, 2005) Cholesterol-lowering agents, such as the widely-prescribed statin drugs, and cholesterol-blocking agents may prove to be "novel therapeutic agents to modify cellular calcium that contributes to the development of pulmonary hypertension," according Hemal H. Patel who lead a multidisciplinary team of researchers at the University of California, San Diego (UCSD).

In studying idiopathic pulmonary hypertension (PPH), formerly called primary pulmonary hypertension, the UCSD team found "a previously unappreciated cellular and molecular mechanism for the disease process," Patel said, "which may be amenable to treatment with current and future therapies and might provide more substantial, long-term and efficacious benefit to those that have IPAH."

Patel is presenting the research at the 35th Congress of the International Union of Physiological Sciences in San Diego, March 31 - April 5, 2005.

*Paper presentation: "Cholesterol-depleting drugs, including statins, lower intracellular Ca2+ and inhibit proliferation in pulmonary artery smooth muscle cells in primary pulmonary hypertension," 12:30 p.m.-3 p.m. Tuesday April 5, Physiology 933.6/board #A446. On view 7:30 a.m. - 4 p.m.

*Featured topic: Patel will participate in Session 898, "Overview: From organelles to organ," a featured topic of the IUPS Calcium Signaling Track, Tuesday beginning at 10:30 a.m., Convention Center room 29C. Patel's presentation is scheduled for noon.

All researchers involved in the study are from UCSD: Hemal H. Patel, Fiona Murray and Paul A. Insel, Department of Pharmacology; Shen Zhang and Jason X-J Yuan, Dept. of Medicine, and Patricia A. Thistlethwaite, Dept. of Surgery.

Research aimed at cellular calcium-dependent aspects of hypertension

IPAH is a severe clinical disease. The prognosis of PPH is poor with untreated disease leading to heart failure and death in two to eight years, Patel noted. Because of limi
'"/>


3-Apr-2005


Page: 1 2 3

Related biology news :

1. Study finds gender differences in renal and other genes contributing to blood pressure
2. Pregnant mothers join search for causes of autism
3. 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
4. Innovative research technique reveals another natural wonder in Yellowstone Park
5. Mother-of-pearl -- Classic beauty and remarkable strength
6. The fisherman is a predator like any other
7. Nanoparticles carry chemotherapy drug deeper into solid tumors
8. A faster way to recover from chemotherapy and marrow transplant
9. Another sexual attraction is possible ...
10. Study suggests other causes for childhood brain aneurysms
11. Sensitivity to diverse range of chemotherapeutic drugs linked to common pathway

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/1/2020)... ... July 01, 2020 , ... Cure Glioblastoma, a registered 501(c)(3) ... and aggressive adult brain cancer—announced today the appointments of its first Senior Fellows: ... supporting the organization’s initiatives and overall vision. , "Senior Fellows are more than ...
(Date:6/28/2020)... ... ... In an upcoming episode scheduled for the fall of 2020, Advancements with Ted ... local listings for more info. , Today, the majority of testing is performed at ... the country. Results are then available several days later. Now, in an effort to ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... today announced that the company has received ISO9001:2015 certification for the development ... research industries. The decision to pursue ISO9001 accreditation demonstrates Kemp’s commitment to ...
Breaking Biology News(10 mins):
(Date:6/11/2020)... ... June 09, 2020 , ... Reducing carbon emissions has been and will continue ... to stock market dips, ways to reduce CO2 is something we can’t avoid. ... of the biofuels being produced today are created from recycled cooking oil or crops. ...
(Date:5/30/2020)... ... 2020 , ... The Conference Forum is pleased to announce ... the unique role of the Chief Medical Officer in the biotech industry. The ... practices and career development of CMOs and Heads of R&D from different therapeutic ...
(Date:5/21/2020)... ... 2020 , ... Threats to intellectual property, political pressure to ... conventional wisdom that says the coronavirus pandemic will generally benefit biopharmaceutical companies, a ... pandemic commercially weaker, dealing with delays in new product launches and with fewer ...
(Date:5/15/2020)... ... May 14, 2020 , ... ... (hMSC) working cell banks and hMSC bioprocess systems, today announced the launch ... of hMSC-derived extracellular vesicles (EVs). RoosterCollect™-EV-CC is the only system designed with ...
Breaking Biology Technology:
Cached News: